AI Visualize v. Nuance: Federal Circuit Affirms Dismissal in Medical Imaging Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | AI Visualize, Inc. v. Nuance Communications Corp. et al. |
| Case Number | 22-2109 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District Court |
| Duration | Aug 2022 – Apr 2024 604 days |
| Outcome | Defendant Win — Dismissal Affirmed |
| Patents at Issue | |
| Accused Products | Method and system for fast access to advanced visualization of medical scans using a dedicated web portal |
Case Overview
The Parties
⚖️ Plaintiff
A patent holder asserting intellectual property rights related to advanced web-based visualization platforms for medical imaging. The company’s IP portfolio targets the intersection of cloud-based access and diagnostic imaging.
🛡️ Defendants
Nuance, a Microsoft subsidiary, is a major player in AI-powered healthcare technology. Mach7 is a medical imaging IT company specializing in enterprise imaging platforms. Both offer radiology workflow solutions.
The Patents at Issue
Four U.S. patents were asserted by AI Visualize, collectively covering methods and systems enabling fast access to advanced visualization of medical scans through a dedicated web portal. This technology area is of growing commercial significance in healthcare IT.
- • US8701167B2 — Web-based visualization systems for medical scan data
- • US9106609B2 — Systems for browser-based diagnostic imaging without local software
- • US9438667B2 — Methods for fast access to advanced visualization of medical scans via web portal
- • US10930397B2 — Infrastructure for cloud-based access and diagnostic imaging
Developing health IT solutions?
Check if your web-based medical imaging solution might infringe similar patents before launch.
The Verdict & Legal Analysis
Outcome
The Federal Circuit **affirmed** the lower court’s ruling, and the appeal was **dismissed**, closing the case as of April 4, 2024. No specific damages award or injunctive relief was identified in the case record, which is consistent with a dismissal outcome rather than a merits adjudication on infringement liability.
Key Legal Issues
The affirmance of dismissal — rather than a finding of non-infringement after full trial — suggests the case may have been resolved at a pretrial procedural threshold. In Federal Circuit patent appeals, dismissals frequently arise from claim construction rulings, subject matter eligibility challenges under 35 U.S.C. § 101 (particularly prevalent for software-implemented and web-based medical systems), or standing/pleading deficiencies.
Given the technology at issue — web portal-based access to medical visualization — § 101 eligibility challenges are a credible procedural basis for early dismissal. Federal courts have scrutinized software patents in healthcare IT under the *Alice Corp. v. CLS Bank International* framework, and patents directed at “fast access” via web portals can be characterized as abstract ideas absent sufficiently inventive technical implementation.
This affirmance carries meaningful precedential weight for **web-based medical imaging patents**, a category that straddles software patent eligibility doctrine and healthcare IT claim drafting practice. It reinforces the difficulty of sustaining broad software-implemented claims at the appellate level in the Federal Circuit, particularly where accused products involve established web delivery architectures.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in medical imaging and health informatics. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this medical imaging patent litigation.
- Identify vulnerabilities in web-based medical imaging patents
- Analyze defense strategies against software-implemented claims
- Review the Federal Circuit’s approach to § 101 challenges
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own medical imaging or health IT products.
- Input your product description or technical features
- AI identifies potentially blocking software patents
- Get actionable risk assessment report, including § 101 insights
High Risk Area
Web portal-based medical imaging patents
4 Patents at Issue
Software-implemented visualization claims
§ 101 Eligibility
Key defense for abstract ideas
✅ Key Takeaways
Federal Circuit affirmance of dismissal in a multi-patent infringement action reinforces procedural defense strategies as cost-effective tools.
Search related case law →Web-based method patents in healthcare IT remain vulnerable to § 101 challenges; claim drafting must anticipate this.
Explore precedents →Four-patent assertion portfolios require coordinated claim construction strategies — weakness in one patent can undermine the entire assertion.
Analyze claim construction trends →Frequently Asked Questions
Four U.S. patents were asserted: US8701167B2, US9106609B2, US9438667B2, and US10930397B2. These patents cover web portal-based fast access to advanced medical scan visualization methods and systems.
The Federal Circuit affirmed the lower court’s ruling and dismissed the appeal on April 4, 2024, closing the case after 604 days. This means the dismissal of AI Visualize’s infringement claims was upheld.
This ruling reinforces the viability of early dismissal strategies, particularly § 101 eligibility challenges, in web-based medical imaging patent cases. It highlights the difficulties in sustaining broad software-implemented claims in the Federal Circuit.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- United States Court of Appeals for the Federal Circuit — Case No. 22-2109
- USPTO Patent Center
- PACER (Public Access to Court Electronic Records)
- Cornell Legal Information Institute — 35 U.S.C. § 101
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.